Influencers on social media, including Facebook (META), Instagram, and YouTube (GOOGL), are talking up weight loss drugs, but are not always revealing the risks of taking this type of drug, Peter Loftus and Sara O’Brien of The Wall Street Journal report. The virtual word-of-mouth has convinced many to take the weight-loss drug, but side effects, such as painful headaches and vomiting, are often omitted or downplayed. Novo Nordisk’s (NVO) Ozempic and Wegovy as well as Eli Lilly’s (LLY) Mounjaro and Zepbound are the first of the weight-loss medicines to become social-media sensations.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on META:
- META Gains after Integrating AI into Its Apps
- EDPB: Meta should give users free option without targeted ads, Reuters reports
- JMP Securities tech/software analysts hold analyst/industry conference call
- #SocialStocks: Trump Media tumbles after share sale and streaming announcement
- Piper Sandler chief investment strategist holds analyst/industry conference call